Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Holt

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Cell|June 15, 1990
Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic miceY Matsui, S A Halter, J T Holt, et al.
Biochimica Et Biophysica Acta|November 28, 1983
Glutamate dehydrogenase in Reye's syndrome. Evidence for the presence of an altered enzyme in serum with increased susceptibility to inhibition by GTPJ T Holt, D A Arvan, T Mayer, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|May 1, 1992
Transforming growth factor beta 1 regulation of c-myc expression, pRB phosphorylation, and cell cycle progression in keratinocytesK Münger, J A Pietenpol, M R Pittelkow, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1988
Specific inhibition of c-myc protein biosynthesis using an antisense synthetic deoxy-oligonucleotide in human T lymphocytesA Harel-Bellan, D K Ferris, M Vinocour, et al.
Journal of Cellular Physiology|February 1, 1992
Differential induction of the c-fos promoter through distinct PDGF receptor-mediated signaling pathwaysK E Salhany, C Robinson-Benion, A F Candia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Ovarian cancer BRCA1 gene therapy: Phase I and II trial differences in immune response and vector stabilityD L Tait, P S Obermiller, A R Hatmaker, et al.
Nature Genetics|April 1, 1995
Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progressionM E Thompson, R A Jensen, P S Obermiller, et al.
Breast Disease|February 3, 2005
Gene therapy for breast and ovarian cancer with BRCA1D L Tait, R A Jensen, J T Holt, et al.
The Journal of Biological Chemistry|June 22, 1999
BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repairD W Abbott, M E Thompson, C Robinson-Benion, et al.
Surgery|March 1, 1993
In vivo regional delivery of retrovirally mediated foreign genes to rat liver cells: need for partial hepatectomy for successful foreign gene expressionA D Moscioni, J Rozga, D F Neuzil, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Cell|June 15, 1990
Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic miceY Matsui, S A Halter, J T Holt, et al.
Biochimica Et Biophysica Acta|November 28, 1983
Glutamate dehydrogenase in Reye's syndrome. Evidence for the presence of an altered enzyme in serum with increased susceptibility to inhibition by GTPJ T Holt, D A Arvan, T Mayer, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|May 1, 1992
Transforming growth factor beta 1 regulation of c-myc expression, pRB phosphorylation, and cell cycle progression in keratinocytesK Münger, J A Pietenpol, M R Pittelkow, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1988
Specific inhibition of c-myc protein biosynthesis using an antisense synthetic deoxy-oligonucleotide in human T lymphocytesA Harel-Bellan, D K Ferris, M Vinocour, et al.
Journal of Cellular Physiology|February 1, 1992
Differential induction of the c-fos promoter through distinct PDGF receptor-mediated signaling pathwaysK E Salhany, C Robinson-Benion, A F Candia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Ovarian cancer BRCA1 gene therapy: Phase I and II trial differences in immune response and vector stabilityD L Tait, P S Obermiller, A R Hatmaker, et al.
Nature Genetics|April 1, 1995
Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progressionM E Thompson, R A Jensen, P S Obermiller, et al.
Breast Disease|February 3, 2005
Gene therapy for breast and ovarian cancer with BRCA1D L Tait, R A Jensen, J T Holt, et al.
The Journal of Biological Chemistry|June 22, 1999
BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repairD W Abbott, M E Thompson, C Robinson-Benion, et al.
Surgery|March 1, 1993
In vivo regional delivery of retrovirally mediated foreign genes to rat liver cells: need for partial hepatectomy for successful foreign gene expressionA D Moscioni, J Rozga, D F Neuzil, et al.
Pageof 6